Identification of a novel chemotherapy benefit index for patients with advanced ovarian cancer based on Bayesian network analysis.
<h4>Background</h4>This study aims to evaluate the efficacy of chemotherapy and optimize treatment strategies for patients with advanced ovarian cancer.<h4>Methods</h4>Based on The Cancer Genome Atlas (TCGA) transcriptome data, we conducted correlation and Bayesian network an...
Saved in:
| Main Authors: | Shuxiao Ma, Lu Zhou, Yi Liu, Hui Jie, Min Yi, Chenglin Guo, Jiandong Mei, Chuan Li, Lei Zhu, Senyi Deng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0322130 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of a novel chemotherapy benefit index for patients with advanced ovarian cancer based on Bayesian network analysis
by: Shuxiao Ma, et al.
Published: (2025-01-01) -
Nanotechnology‐Driven Drug Delivery Systems for Lung Cancer: Computational Advances and Clinical Perspectives
by: Min Yi, et al.
Published: (2025-07-01) -
Benefits of Pelvic and Para-Aortic Lymphadenectomy after Neoadjuvant Chemotherapy for Advanced Epithelial Ovarian Cancer with Enlarged Lymph Nodes
by: Michiko Kubo-Kaneda, et al.
Published: (2023-04-01) -
New prognostic index for neoadjuvant chemotherapy outcome in patients with advanced high-grade serous ovarian cancer
by: Chuying Huo, et al.
Published: (2024-12-01) -
Neoadjuvant chemotherapy for advanced ovarian cancer: literature data and in vitro studies
by: S. A. Kuznetsov, et al.
Published: (2015-09-01)